These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27066910)

  • 1. Genetic and Phenotypic Analysis of CRF01_AE HIV-1 env Clones from Patients Residing in Beijing, China.
    Chen D; He X; Ye J; Zhao P; Zeng Y; Feng X
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1113-1124. PubMed ID: 27066910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies.
    Wang H; Yuan T; Li T; Li Y; Qian F; Zhu C; Liang S; Hoffmann D; Dittmer U; Sun B; Yang R
    Arch Virol; 2018 Dec; 163(12):3303-3315. PubMed ID: 30196320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic and phenotypic characterization of HIV-1 CRF01_AE env molecular clones from infections in China.
    Nie J; Zhang C; Liu W; Wu X; Li F; Wang S; Liang F; Song A; Wang Y
    J Acquir Immune Defic Syndr; 2010 Apr; 53(4):440-50. PubMed ID: 20090544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand.
    Utachee P; Jinnopat P; Isarangkura-Na-Ayuthaya P; de Silva UC; Nakamura S; Siripanyaphinyo U; Wichukchinda N; Tokunaga K; Yasunaga T; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    Microbes Infect; 2009 Mar; 11(3):334-43. PubMed ID: 19136072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.
    Wang S; Nie J; Wang Y
    Virus Res; 2011 Jan; 155(1):137-46. PubMed ID: 20875470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.
    Utachee P; Isarangkura-na-ayuthaya P; Tokunaga K; Ikuta K; Takeda N; Kameoka M
    Retrovirology; 2014 Apr; 11():32. PubMed ID: 24758333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.
    Wang W; Nie J; Prochnow C; Truong C; Jia Z; Wang S; Chen XS; Wang Y
    Retrovirology; 2013 Feb; 10():14. PubMed ID: 23384254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
    Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M
    Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
    Utachee P; Nakamura S; Isarangkura-Na-Ayuthaya P; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    J Virol; 2010 May; 84(9):4311-20. PubMed ID: 20164234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the evolutionary pressure on the env gene of the human immunodeficiency virus type 1 CRF01-AE strains circulating in China].
    Liang H; Xing H; Wei M; Chen Z; Guan Q; Huang HL; Quan Y; Chen JP; Hong KX; Shi LY; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):966-70. PubMed ID: 14687493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of HIV-1 CRF01_AE
    Sasaki M; Kotaki T; Khairunisa SQ; Tachibana S; Ophinni Y; Hayashi Y; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2020 Mar; 36(3):242-247. PubMed ID: 31580700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of signature amino acids in the env V3-V4 and flanking regions of human immunodeficiency virus type 1 predominant strains in China].
    Liang H; Xing H; Li JZ; Wei M; Hong KX; Feng Y; Zhao QB; Chen JP; Quan Y; Teng T; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):897-902. PubMed ID: 16029528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring substitutions of conserved residues in human immunodeficiency virus type 1 variants of different clades are involved in PG9 and PG16 resistance to neutralization.
    Thenin S; Roch E; Samleerat T; Moreau T; Chaillon A; Moreau A; Barin F; Braibant M
    J Gen Virol; 2012 Jul; 93(Pt 7):1495-1505. PubMed ID: 22492917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand.
    Utachee P; Jinnopat P; Isarangkura-Na-Ayuthaya P; de Silva UC; Nakamura S; Siripanyaphinyo U; Wichukchinda N; Tokunaga K; Yasunaga T; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):229-36. PubMed ID: 19108694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of recombinant human immunodeficiency virus type-1 CRF01_AE strains in China and its sequence variations in the env V3-C3 region].
    Xing H; Liang H; Wan ZY; Chen X; Wei M; Ma PF; Guan Q; Quan Y; Hong KX; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):300-4. PubMed ID: 15498240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses.
    Thida W; Kuwata T; Maeda Y; Yamashiro T; Tran GV; Nguyen KV; Takiguchi M; Gatanaga H; Tanaka K; Matsushita S
    Biochem Biophys Res Commun; 2019 Jan; 508(1):46-51. PubMed ID: 30470571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B' env molecular clones derived from infections in China.
    Xie H; Nie J; Chen Q; Huang W; Wang Y
    Emerg Microbes Infect; 2018 May; 7(1):90. PubMed ID: 29769530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
    Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE viruses.
    O'Rourke SM; Sutthent R; Phung P; Mesa KA; Frigon NL; To B; Horthongkham N; Limoli K; Wrin T; Berman PW
    PLoS One; 2015; 10(3):e0119608. PubMed ID: 25793890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological characteristics of predominant strains of HIV-1 genotype: modeling of HIV-1 infection among men who have sex with men.
    Dai D; Shang H; Han XX; Zhao B; Liu J; Ding HB; Xu JJ; Chu ZX
    J Med Virol; 2015 Apr; 87(4):557-68. PubMed ID: 25655808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.